{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T07:29:25Z","timestamp":1773041365857,"version":"3.50.1"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Zhejiang medical and health science","award":["2017KY305"],"award-info":[{"award-number":["2017KY305"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81302840"],"award-info":[{"award-number":["81302840"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Regulatory Toxicology and Pharmacology"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.yrtph.2018.07.001","type":"journal-article","created":{"date-parts":[[2018,7,7]],"date-time":"2018-07-07T13:46:48Z","timestamp":1530971208000},"page":"24-30","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Determination of chidamide in rat plasma and cerebrospinal fluid"],"prefix":"10.1016","volume":"98","author":[{"given":"Haiyan","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cong","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhongjian","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanzhou","family":"Mou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9053-2355","authenticated-orcid":false,"given":"Liqiang","family":"Gu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"17","key":"10.1016\/j.yrtph.2018.07.001_bib1","doi-asserted-by":"crossref","first-page":"3896","DOI":"10.1182\/blood-2008-10-182253","article-title":"CNS events in elderly patients with aggressive lymphoma treated with modern chemotherapy (CHOP-14) with or without rituximab: an analysis of patients treated in the RICOVER-60 trial of the German High-Grade Non-Hodgkin Lymphoma Study Group (DSHNHL)","volume":"113","author":"Boehme","year":"2009","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.yrtph.2018.07.001_bib2","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1080\/10428194.2016.1222375","article-title":"Durable clinical remission induced by romidepsin for chemotherapy-refractory peripheral T-cell lymphoma with central nervous system involvement","volume":"58","author":"Chan","year":"2017","journal-title":"Leuk. Lymphoma"},{"issue":"2","key":"10.1016\/j.yrtph.2018.07.001_bib3","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1002\/ijc.31052","article-title":"The impact of P-glycoprotein and breast cancer resistance protein on the brain pharmacokinetics and pharmacodynamics of a panel of MEK inhibitors","volume":"142","author":"de Gooijer","year":"2018","journal-title":"Int. J. Canc."},{"issue":"10","key":"10.1016\/j.yrtph.2018.07.001_bib4","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1002\/cncr.20999","article-title":"Prognostic factors and treatment of patients with T-cell non-Hodgkin lymphoma: the M. D. Anderson Cancer Center experience","volume":"103","author":"Escalon","year":"2005","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.yrtph.2018.07.001_bib5","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1093\/annonc\/mdh013","article-title":"Incidence and risk factors for central nervous system occurrence in elderly patients with diffuse large-B-cell lymphoma: influence of rituximab","volume":"15","author":"Feugier","year":"2004","journal-title":"Ann. Oncol. : Official J Eur Soc Med Oncol \/ ESMO"},{"issue":"3","key":"10.1016\/j.yrtph.2018.07.001_bib6","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1042\/BJ20111685","article-title":"CS055 (Chidamide\/HBI-8000), a novel histone deacetylase inhibitor, induces G1 arrest, ROS-dependent apoptosis and differentiation in human leukaemia cells","volume":"443","author":"Gong","year":"2012","journal-title":"Biochem. J."},{"key":"10.1016\/j.yrtph.2018.07.001_bib7","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.jchromb.2015.07.001","article-title":"Development and validation of a sensitive HPLC-MS\/MS method for determination of chidamide (epidaza), a new benzamide class of selective histone deacetylase inhibitor, in human plasma and its clinical application","volume":"1000","author":"Gu","year":"2015","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"issue":"5","key":"10.1016\/j.yrtph.2018.07.001_bib8","doi-asserted-by":"crossref","first-page":"561","DOI":"10.3109\/0284186X.2015.1118656","article-title":"Central nervous system involvement in T-cell lymphoma: a single center experience","volume":"55","author":"Gurion","year":"2016","journal-title":"Acta Oncol."},{"issue":"6","key":"10.1016\/j.yrtph.2018.07.001_bib9","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1023\/A:1008394827806","volume":"11","author":"Haioun","year":"2000","journal-title":"Ann. Oncol. : Official J Eur Soc Med Oncol \/ ESMO"},{"issue":"7","key":"10.1016\/j.yrtph.2018.07.001_bib10","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1093\/annonc\/mdf175","article-title":"Central nervous system involvement following diagnosis of non-Hodgkin's lymphoma: a risk model","volume":"13","author":"Hollender","year":"2002","journal-title":"Ann. Oncol. : Official J Eur Soc Med Oncol \/ ESMO"},{"issue":"4","key":"10.1016\/j.yrtph.2018.07.001_bib11","doi-asserted-by":"crossref","first-page":"444","DOI":"10.21147\/j.issn.1000-9604.2016.04.08","article-title":"A phase I trial of an oral subtype-selective histone deacetylase inhibitor, chidamide, in combination with paclitaxel and carboplatin in patients with advanced non-small cell lung cancer","volume":"28","author":"Hu","year":"2016","journal-title":"Chin. J. Canc. Res."},{"issue":"8","key":"10.1016\/j.yrtph.2018.07.001_bib12","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1023\/A:1008418727472","article-title":"Montserrat E: peripheral T-cell lymphomas: initial features, natural history, and prognostic factors in a series of 174 patients diagnosed according to the R.E.A.L. Classification","volume":"9","author":"Lopez-Guillermo","year":"1998","journal-title":"Ann. Oncol. : Official J Eur Soc Med Oncol \/ ESMO"},{"issue":"4","key":"10.1016\/j.yrtph.2018.07.001_bib13","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1007\/s00280-011-1766-x","article-title":"Chidamide (CS055\/HBI-8000): a new histone deacetylase inhibitor of the benzamide class with antitumor activity and the ability to enhance immune cell-mediated tumor cell cytotoxicity","volume":"69","author":"Ning","year":"2012","journal-title":"Canc. Chemother. Pharmacol."},{"issue":"10","key":"10.1016\/j.yrtph.2018.07.001_bib14","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1093\/annonc\/mdh392","article-title":"Characterization of peripheral T-cell lymphomas in a single North American institution by the WHO classification","volume":"15","author":"Savage","year":"2004","journal-title":"Ann. Oncol. : Official J Eur Soc Med Oncol \/ ESMO"},{"issue":"18","key":"10.1016\/j.yrtph.2018.07.001_bib15","doi-asserted-by":"crossref","first-page":"3418","DOI":"10.1182\/blood-2010-02-270785","article-title":"Treatment and prognosis of mature T-cell and NK-cell lymphoma: an analysis of patients with T-cell lymphoma treated in studies of the German high-grade non-Hodgkin lymphoma study group","volume":"116","author":"Schmitz","year":"2010","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.yrtph.2018.07.001_bib16","doi-asserted-by":"crossref","DOI":"10.1088\/1478-3975\/aa708a","article-title":"Physical insights into the blood-brain barrier translocation mechanisms","volume":"14","author":"Theodorakis","year":"2017","journal-title":"Phys. Biol."},{"issue":"4","key":"10.1016\/j.yrtph.2018.07.001_bib17","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1182\/blood.V91.4.1178","article-title":"Risk factors, treatment, and outcome of central nervous system recurrence in adults with intermediate-grade and immunoblastic lymphoma","volume":"91","author":"van Besien","year":"1998","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.yrtph.2018.07.001_bib18","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1002\/bmc.3001","article-title":"Determination of chidamide in rat plasma by LC-MS and its application to pharmacokinetics study","volume":"27","author":"Wang","year":"2013","journal-title":"Biomed. Chromatogr."},{"issue":"8","key":"10.1016\/j.yrtph.2018.07.001_bib19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0070522","article-title":"Increased PRAME-specific CTL killing of acute myeloid leukemia cells by either a novel histone deacetylase inhibitor chidamide alone or combined treatment with decitabine","volume":"8","author":"Yao","year":"2013","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.yrtph.2018.07.001_bib20","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1093\/annonc\/mdq645","article-title":"Elevated LDH and paranasal sinus involvement are risk factors for central nervous system involvement in patients with peripheral T-cell lymphoma","volume":"22","author":"Yi","year":"2011","journal-title":"Ann. Oncol.: Official J Eur Soc Med Oncol \/ ESMO"},{"issue":"3","key":"10.1016\/j.yrtph.2018.07.001_bib21","doi-asserted-by":"crossref","first-page":"258","DOI":"10.6004\/jnccn.2006.0025","article-title":"National Comprehensive Cancer N: non-Hodgkin's lymphoma. Clinical practice guidelines in oncology","volume":"4","author":"Zelenetz","year":"2006","journal-title":"J. Natl. Compr. Canc. Netw. : J. Natl. Compr. Canc. Netw."},{"issue":"4","key":"10.1016\/j.yrtph.2018.07.001_bib22","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.biopha.2014.03.011","article-title":"Non-toxic dose chidamide synergistically enhances platinum-induced DNA damage responses and apoptosis in Non-Small-Cell lung cancer cells","volume":"68","author":"Zhou","year":"2014","journal-title":"Biomed Pharmacother = Biomedecine Pharmacotherapie"}],"container-title":["Regulatory Toxicology and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S027323001830179X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S027323001830179X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,10,20]],"date-time":"2019-10-20T09:20:04Z","timestamp":1571563204000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S027323001830179X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":22,"alternative-id":["S027323001830179X"],"URL":"https:\/\/doi.org\/10.1016\/j.yrtph.2018.07.001","relation":{},"ISSN":["0273-2300"],"issn-type":[{"value":"0273-2300","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Determination of chidamide in rat plasma and cerebrospinal fluid","name":"articletitle","label":"Article Title"},{"value":"Regulatory Toxicology and Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yrtph.2018.07.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}